Greg Foltz

11.9k total citations
19 papers, 725 citations indexed

About

Greg Foltz is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Greg Foltz has authored 19 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Oncology. Recurrent topics in Greg Foltz's work include Glioma Diagnosis and Treatment (5 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Cells and Metastasis (4 papers). Greg Foltz is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Cells and Metastasis (4 papers). Greg Foltz collaborates with scholars based in United States, Canada and Italy. Greg Foltz's co-authors include Jae‐Geun Yoon, Hwahyung Lee, Leroy Hood, Nameeta Shah, Anup Madan, Zita A. Sibenaller, Parvinder Hothi, Brent A. Reynolds, Timothy C. Ryken and Timothy J. Martins and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Greg Foltz

18 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Foltz United States 11 502 219 208 155 82 19 725
Jun-Kyum Kim South Korea 14 428 0.9× 206 0.9× 213 1.0× 214 1.4× 67 0.8× 17 755
Han Shen Australia 16 494 1.0× 185 0.8× 263 1.3× 128 0.8× 63 0.8× 37 760
Ozlem Aksoy United States 7 744 1.5× 248 1.1× 241 1.2× 260 1.7× 109 1.3× 8 1.2k
Parvinder Hothi United States 11 280 0.6× 149 0.7× 152 0.7× 147 0.9× 83 1.0× 14 508
Fatima W. Khwaja United States 7 496 1.0× 272 1.2× 440 2.1× 185 1.2× 65 0.8× 7 872
Kah Suan Lim United States 10 538 1.1× 177 0.8× 173 0.8× 157 1.0× 42 0.5× 14 754
Alexandra Borodovsky United States 14 698 1.4× 312 1.4× 229 1.1× 220 1.4× 79 1.0× 26 1.0k
Kruttika Bhat United States 13 393 0.8× 238 1.1× 239 1.1× 289 1.9× 96 1.2× 21 806
Marta Viana‐Pereira Portugal 14 422 0.8× 363 1.7× 277 1.3× 178 1.1× 123 1.5× 23 787
Violaine Goidts Germany 15 582 1.2× 214 1.0× 273 1.3× 306 2.0× 57 0.7× 21 878

Countries citing papers authored by Greg Foltz

Since Specialization
Citations

This map shows the geographic impact of Greg Foltz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Foltz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Foltz more than expected).

Fields of papers citing papers by Greg Foltz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Foltz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Foltz. The network helps show where Greg Foltz may publish in the future.

Co-authorship network of co-authors of Greg Foltz

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Foltz. A scholar is included among the top collaborators of Greg Foltz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Foltz. Greg Foltz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Funk, Cory C., Juan Caballero-Pérez, Nameeta Shah, et al.. (2017). A Cell-Surface Membrane Protein Signature for Glioblastoma. Cell Systems. 4(5). 516–529.e7. 37 indexed citations
2.
Kalkanis, Steven N., Manish K. Aghi, George Kaptain, et al.. (2015). DDEL-06PRELIMINARY SAFETY OF TOCA 511, A RETROVIRAL REPLICATING VECTOR, IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ACROSS THREE SEPARATE PHASE 1 STUDIES. Neuro-Oncology. 17(suppl 5). v74.2–v74. 3 indexed citations
3.
Puchalski, Ralph B., Nameeta Shah, Jeremy A. Miller, et al.. (2015). GENO-32AN ANATOMIC TRANSCRIPTIONAL ATLAS OF GLIOBLASTOMA. Neuro-Oncology. 17(suppl 5). v99.1–v99. 1 indexed citations
4.
Schroeder, Brett, et al.. (2015). Genetic investigation of multicentric glioblastoma multiforme: case report. Journal of neurosurgery. 124(5). 1353–1358. 6 indexed citations
5.
Shah, Nameeta, et al.. (2013). Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data. BMC Genomics. 14(1). 818–818. 69 indexed citations
6.
Rostad, Steven, et al.. (2012). Cellular pleomorphism in papillary tumors of the pineal region. Brain Tumor Pathology. 30(2). 93–98. 9 indexed citations
7.
Hothi, Parvinder, Timothy J. Martins, Liping Chen, et al.. (2012). High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells. Oncotarget. 3(10). 1124–1136. 135 indexed citations
8.
Lin, Bingqing, et al.. (2012). BEX1 (brain expressed, X-linked 1). Atlas of Genetics and Cytogenetics in Oncology and Haematology.
9.
Lin, Benjamin, Xi Huang, Xu Han, & Greg Foltz. (2012). SOX2 (SRY (sex determining region Y)-box 2). Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2 indexed citations
10.
Shah, Nameeta, Biaoyang Lin, Zita A. Sibenaller, et al.. (2011). Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM. PLoS ONE. 6(1). e16146–e16146. 84 indexed citations
11.
Panchalingam, Krishna M., Parvinder Hothi, Nameeta Shah, et al.. (2011). Large-Scale Production of Human Glioblastoma-Derived Cancer Stem Cell Tissue in Suspension Bioreactors to Facilitate the Development of Novel Oncolytic Therapeutics. BiblioBoard Library Catalog (Open Research Library). 3 indexed citations
12.
Panchalingam, Krishna M., Nameeta Shah, Anup Madan, et al.. (2009). Bioprocessing of Human Glioblastoma Brain Cancer Tissue. Tissue Engineering Part A. 16(4). 1169–1177. 13 indexed citations
13.
Tu, Lan N., Greg Foltz, Edward H. Lin, Leroy Hood, & Qiang Tian. (2009). Targeting Stem Cells-Clinical Implications for Cancer Therapy. Current Stem Cell Research & Therapy. 4(2). 147–153. 44 indexed citations
14.
Foltz, Greg, Jung‐Hoon Yoon, T C Ryken, et al.. (2009). DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis. Oncogene. 28(29). 2667–2677. 44 indexed citations
15.
Lipson, Adam C., Greg Foltz, G. Alexander West, David W. Newell, & Gavin W. Britz. (2008). Late de novo basilar aneurysm after carotid artery injury. Journal of neurosurgery. 108(3). 607–607. 2 indexed citations
16.
Price, Nathan D., Greg Foltz, Anup Madan, Leroy Hood, & Qiang Tian. (2007). Systems biology and cancer stem cells. Journal of Cellular and Molecular Medicine. 12(1). 97–110. 17 indexed citations
17.
Vibhakar, Rajeev, Greg Foltz, Jae‐Geun Yoon, et al.. (2007). Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma1. Neuro-Oncology. 9(2). 135–144. 61 indexed citations
18.
Foltz, Greg, Jae‐Geun Yoon, Timothy Nelson, et al.. (2006). Genome-Wide Analysis of Epigenetic Silencing Identifies BEX1 and BEX2 as Candidate Tumor Suppressor Genes in Malignant Glioma. Cancer Research. 66(13). 6665–6674. 122 indexed citations
19.
Kinoshita, Yoshito, Abel Jarell, Jean‐Michel Flaman, et al.. (2001). Pescadillo, a Novel Cell Cycle Regulatory Protein Abnormally Expressed in Malignant Cells. Journal of Biological Chemistry. 276(9). 6656–6665. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026